Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMe for Chemoprevention of Colorectal Adenomas
NCT07582003Phase 1Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of S-adenosylmethionine in Colorectal Adenoma (CRA) and colorectal cancer (CRC). Primary endpoint: Recommended Phase II Dose at 4 weeks. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
S-adenosylmethionine
03
Conditions
Colorectal Adenoma (CRA)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07582003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07582003.